Trevi Therapeutics (TRVI) P/E (2019 - 2026)
Trevi Therapeutics (TRVI) P/E from Jul 1, 2019 to Jul 21, 2026. The TTM Trevi Therapeutics (TRVI) P/E is -50.42. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Trevi Therapeutics (TRVI)
| Year | P/E | Change |
|---|---|---|
| 2026 | -50.42 | +45.53% |
| 2025 | -34.64 | +426.01% |
| 2024 | -6.59 | +112.35% |
| 2023 | -3.10 | +41.63% |
| 2022 | -2.19 | +338.52% |
| 2021 | -0.50 | -62.76% |
| 2020 | -1.34 | -57.39% |
| 2019 | -3.15 | N/A |
Comparison Trevi Therapeutics (TRVI) P/E with competitors
Trevi Therapeutics (TRVI) P/E is -50.42.